ARCHIVES

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

This article is from The Cancer Letter archive.

Vol. 39 No. 05 | February 1, 2013

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

Cancer Deaths Level Off For First Time, Klausner Tells House Appropriators.

February 18, 2000

After a “humble” start at NCI, von Eschenbach set unachievable goal.

September 30, 2005

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Clinical Education Guidelines Proposed

April 4, 1975